Timing and benefit of liver transplantation in acute liver failure

被引:97
作者
O'Grady, John [1 ]
机构
[1] Kings Coll Hosp London, Inst Liver Studies, London SE5 9RS, England
关键词
Acute liver failure; Liver transplantation; Transplant benefit; Prognostic models; Futility; FULMINANT HEPATIC-FAILURE; COLLEGE-HOSPITAL CRITERIA; SINGLE-CENTER EXPERIENCE; UNITED-STATES; MELD SCORE; PROGNOSTIC-FACTORS; EARLY INDICATORS; BLOOD LACTATE; KINGS-COLLEGE; OUTCOMES;
D O I
10.1016/j.jhep.2013.10.024
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The case for using emergency liver transplantation in acute liver failure was made two decades ago by a series of single centre experiences. The development of models identifying a poor prognosis assisted the selection of patients for liver transplantation but none of these delivers both high sensitivity and specificity for prediction of death. Enhanced sensitivity favours the individual patient while enhanced specificity targets the pool of organs available at those who will derive greatest benefit. The non-transplant survival rates have improved considerably for certain cohorts of patients and these prognostic models have not been adjusted to reflect these changes. The presumption of transplant benefit can no longer be taken as established in paracetamol-related acute liver failure and a policy review is appropriate. In other scenarios, such as seronegative hepatitis and the phenotype of sub-acute liver failure, spontaneous survival rates remain low and the basis for liver transplantation remains sound. Outcomes after liver transplantation are improving but are not yet comparable to elective transplantation. The understanding of factors associated with failure after liver transplantation is improving but accurate definition of futility has not yet been attained. (C) 2013 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:663 / 670
页数:8
相关论文
共 62 条
[11]   ORTHOTOPIC LIVER-TRANSPLANTATION IN FULMINANT AND SUBFULMINANT HEPATITIS - THE PAUL-BROUSSE EXPERIENCE [J].
BISMUTH, H ;
SAMUEL, D ;
CASTAING, D ;
ADAM, R ;
SALIBA, F ;
JOHANN, M ;
AZOULAY, D ;
DUCOT, B ;
CHICHE, L .
ANNALS OF SURGERY, 1995, 222 (02) :109-119
[12]  
Bismuth MD, 1987, ANN INTERN MED, V107, P337
[13]  
BREMS JJ, 1987, AM J SURG, V154, P137
[14]   LIVER-TRANSPLANTATION FOR ACUTE LIVER-FAILURE - ANALYSIS OF APPLICABILITY [J].
CASTELLS, A ;
SALMERON, JM ;
NAVASA, M ;
RIMOLA, A ;
SALO, J ;
ANDREU, H ;
MAS, A ;
RODES, J .
GASTROENTEROLOGY, 1993, 105 (02) :532-538
[15]   LIVER-TRANSPLANTATION FOR ACUTE HEPATIC-FAILURE [J].
CHAPMAN, RW ;
FORMAN, D ;
PETO, R ;
SMALLWOOD, R .
LANCET, 1990, 335 (8680) :32-35
[16]   Systematic review: prognostic tests of paracetamol-induced acute liver failure [J].
Craig, D. G. N. ;
Ford, A. C. ;
Hayes, P. C. ;
Simpson, K. J. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 31 (10) :1064-1076
[17]   Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure [J].
Demetriou, AA ;
Brown, RS ;
Busuttil, RW ;
Fair, J ;
McGuire, BM ;
Rosenthal, P ;
Esch, JSA ;
Lerut, J ;
Nyberg, SL ;
Salizzoni, M ;
Fagan, EA ;
de Hemptinne, B ;
Broelsch, CE ;
Muraca, M ;
Salmeron, JM ;
Rabkin, JM ;
Metselaar, HJ ;
Pratt, D ;
De La Mata, M ;
McChesney, LP ;
Everson, GT ;
Lavin, PT ;
Stevens, AC ;
Pitkin, Z ;
Solomon, BA .
ANNALS OF SURGERY, 2004, 239 (05) :660-667
[18]  
DEVICTOR D, 1992, HEPATOLOGY, V16, P1156, DOI 10.1002/hep.1840160509
[19]   Early indicators of prognosis in fulminant hepatic failure: An assessment of the model for end-stage liver disease (MELD) and King's College Hospital Criteria [J].
Dhiman, Radha K. ;
Jain, Sanjay ;
Maheshwari, Uma ;
Bhalla, Ashish ;
Sharma, Navneet ;
Ahluwalia, Jasmina ;
Duseja, Ajay ;
Chawla, Yogesh .
LIVER TRANSPLANTATION, 2007, 13 (06) :814-821
[20]   The predictive value of admission and follow up factor V and VII levels in patients with acute hepatitis and coagulopathy [J].
Elinav, E ;
Ben-Dov, I ;
Hai-Am, E ;
Ackerman, Z ;
Ofran, Y .
JOURNAL OF HEPATOLOGY, 2005, 42 (01) :82-86